Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men

Thrombosis Research

Volumn 102, Issue 1, 2001, Pages 3-13

  Hansen, John Bjarne ^a   Grimsgaard, Sameline ^a   Huseby, Nils Erik ^a   Sandset, Per Morten ^b   Bonaa, Kaare H ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Coronary risk; Factor VII; Fibrinogen; Serum lipids; Tissue factor pathway inhibitor

Indexed keywords

APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; CHOLESTEROL; FIBRINOGEN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGE; ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; FACTOR VII; FEMALE; FIBRINOGEN; HEMOSTATICS; HUMANS; LINEAR MODELS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; THROMBOPLASTIN;

EID: 0035311196     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00215-8     Document Type: Article

References (47)

1. Tissue factor and haemostasis
2. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation
3. The tissue factor pathway of coagulation: Factor VII, tissue factor, and tissue factor pathway inhibitor
4. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
5. Altered factor VII activity in hemophilia
6. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII
7. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII, but not cofactor function: Analysis of a mutant with selective deficiency in activity
8. Coagulation factor VII, dietary fat and blood lipids: A review
9. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
10. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis
11. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
12. A novel specific immunoassay for plasma two-chain factor VIIa: Investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes
13. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype
14. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action
15. Modifications of extrinsic pathway inhibitor (EPI) factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: Evidence for a two-step model of inhibition
16. Functional significance of the Kunitz-type inhibitor domains of lipoprotein-associated coagulation inhibitor
17. An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma
18. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity
19. Tissue factor pathway inhibitor: The carboxy-terminus is required for optimal inhibition of factor Xa
20. Extrinsic pathway inhibitor: The key to feedback control of blood coagulation initiated by tissue thromboplastin
21. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)
22. Purification and properties of heparin releasable lipoprotein-associated coagulation inhibitor
23. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma
24. Tissue factor pathway inhibitor and lipoproteins: Evidence for association with and regulation by LDL in human plasma
25. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): Levels in the normal population and relation to cholesterol
26. Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system
27. Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia
28. Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro
29. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia
30. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol lowering effects, but divergent effects on plasma fatty acids
31. Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions
32. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
33. An enzyme linked immunosorption assay for tissue factor pathway inhibitor
34. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II
35. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII
36. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations
37. Correlations of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults
38. Factor VII, cholesterol, and triglycerides. The CARDIA study. Coronary artery risk in young adults study
39. Regulation of factor VIIa/tissue factor functional activity in an umbilical vein model
40. The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions
41. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiological role for EPI as a natural anticoagulant
42. Total and free levels of tissue factor pathway inhibitor: A risk factor in patients with factor V Leiden?
43. Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis
44. Increased activation of the haemostatic system in men at high risk for fatal coronary heart disease
45. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease
46. Fibrinogen, factor VII clotting activity and coronary artery disease severity